Le Lézard
Classified in: Health
Subjects: CHI, SVY

CHOP's Center for Autism Research Shows How the Brain's "Reward Circuit" Plays a Key Role in Symptoms of Autism Spectrum Disorder


PHILADELPHIA, June 18, 2018 /PRNewswire-USNewswire/ -- A pair of recent studies performed by researchers at Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania represents a significant step forward in understanding the role of the brain's "reward circuit" and certain hallmarks of autism spectrum disorder (ASD), namely difficulty interpreting or engaging in typical social behavior and restricted or repetitive interests or behaviors.

For years, researchers have attempted to use fMRI brain imaging studies to find a link between these behavioral traits and the way the brain processes rewards among people with and without ASD. Many of these studies sought evidence to support the social motivation hypothesis, which suggests that early in development, children with ASD attend less to social information such as faces or gaze direction, and thus have fewer opportunities for learning through observing others and developing critical social skills.

A team of researchers at CHOP's Center for Autism Research (CAR) applied a newly-developed research method known as seed-based d mapping meta-analysis to combine the results of 13 fMRI studies on how people with ASD process rewards in the brain. In total, these studies included 259 individuals with ASD and 246 typically developing individuals. This meta-analysis revealed that individuals with ASD process social and nonsocial rewards differently than people not diagnosed with ASD. The study is the first to show conclusive imaging evidence that people with ASD find social and nonsocial images less rewarding, with the authors suggesting that future studies examine how the brain processes different types of nonsocial rewards, and how reward processing in ASD changes with age.

The results were published in the journal JAMA Psychiatry and were accompanied by an editorial.

"This study represents one of the first efforts to apply this new meta-analysis method of combining brain activity data from multiple neuroimaging studies to ASD," said Caitlin Clements, a member of the Center for Autism Research (CAR) at CHOP, a doctoral student at the University of Pennsylvania Psychology Department and lead author of the paper. "By analyzing many studies, we hoped to show how the brain processes social and nonsocial rewards in a way that no single study has been able to do on its own. The results suggest that we broaden our understanding of the social motivation hypothesis to include atypical motivation for both social and nonsocial rewards."

This meta-analysis complements neuroimaging research published earlier this year by CAR in the journal Molecular Autism. That paper studied the role of the reward system in repetitive behavior and restricted interests, another hallmark behavior of ASD. Children with ASD activated the reward circuit more for videos of a restricted interest (like the game Minecraft) than for videos of people smiling and giving them a "thumbs up" sign (a social reward). The reward circuit in typically developing children showed the opposite pattern ?more activation for social rewards than interests. This study was one of the largest to-date in ASD, and the findings suggest that the social motivation hypothesis may be expanded to explain the presence of repetitive behaviors and restricted interests.

"These two studies demonstrate a growing body of evidence supporting the idea that there are key differences in how people with ASD process rewarding information in their brain," said Dr. Benjamin Yerys, a psychologist in the Department of Child and Adolescent Psychiatry and Behavioral Sciences at CHOP, senior author of the Molecular Autism study and a co-author of the JAMA Psychiatry study. "By strategically targeting the reward system, we may be able to create more personalized and effective treatment practices that improve outcomes for individuals with ASD and their families."

Funding support for the research in the JAMA Psychiatry paper came from the National Science Foundation Graduate Research Fellowship Program. Funding support for the research in the Molecular Autism paper came from grants from the National Institute of Mental Health under grants K23MH086111, R21MH092615, and RC1MH088791, a New Program Development Award through the Intellectual and Development Disabilities Research Center funded by the National Institute of Child and Human Development under grant P30HD026979, a grant from the Philadelphia Foundation, a grant from the Pennsylvania Department of Health (SAP #4100042728) and additional grants from Pfizer and the Robert Wood Johnson Foundation.

Clements et al, "A meta-analytic evaluation of the Social Motivation Hypothesis of Autism: Processing deficits extend beyond social rewards," JAMA Psychiatry, online June 13, 2018.

Kohls et al, "Altered reward system reactivity for personalized circumscribed interests in autism," Molecular Autism, January 30, 2018.

About Children's Hospital of Philadelphia: Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. In addition, its unique family-centered care and public service programs have brought the 546-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu

Contact: Ben Leach
Children's Hospital of Philadelphia
(267) 426-2857
[email protected] 

SOURCE Children's Hospital of Philadelphia


These press releases may also interest you

at 22:03
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

at 22:00
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

at 21:45
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

at 21:30
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...



News published on and distributed by: